Samoa Wellness Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoa Wellness Report.

Press releases published on August 10, 2026

Aug. 10, 2026

Park Dental Partners, Inc. Announces Agreement to Acquire Village Family Dental Services Organization - Enters North Carolina Market

Indeterminate GlobeNewswire

Aug. 10, 2026

Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

Indeterminate GlobeNewswire

Aug. 10, 2026

Replimune Announces Pricing of $150 Million Underwritten Offering

Indeterminate GlobeNewswire

Aug. 10, 2026

Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

Indeterminate GlobeNewswire

Aug. 10, 2026

Entente Education Canada awards $105,000 in scholarships Investing in the students shaping Canada’s future

Indeterminate GlobeNewswire

Aug. 10, 2026

CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 10, 2026

Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance

Indeterminate GlobeNewswire

Aug. 10, 2026

Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board

Indeterminate GlobeNewswire

Aug. 10, 2026

Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare

Indeterminate GlobeNewswire

Aug. 10, 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 10, 2026

MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 10, 2026

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Indeterminate GlobeNewswire

Aug. 10, 2026

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 10, 2026

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Indeterminate GlobeNewswire

Aug. 10, 2026

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film

Indeterminate GlobeNewswire

Aug. 10, 2026

Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Aug. 10, 2026

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

Indeterminate GlobeNewswire

Aug. 10, 2026

BrewDog Claims London's Summer Park Season with ‘Park IPA’

Indeterminate GlobeNewswire

Aug. 10, 2026

Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 10, 2026

Grey Matters Appoints Radiologist Dr. Jayson A. Lord, MD as Medical Director of its First Dedicated PET Neuroimaging Clinic in the U.S.

Indeterminate GlobeNewswire